All News

Clayton Irvine, PharmD, MBA, MS, notes that although these options help to lower the cost of care, quick, widespread implementation remains difficult.

INCA033989 is a monoclonal antibody that selectively targets mutant calreticulin oncogenic function.

Issues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.

These results indicate the combination’s long-term effectiveness in a population with limited treatment options.

Rahul Banerjee, MD, FACP, discussed his presentation at the International Myeloma Society 2024 Annual Meeting on available T cell-directed therapies for myeloma treatment, including CAR T-cell therapies and bispecific antibodies.

Banerjee addressed factors to consider when selecting a regimen, the available treatments in this category, and their key differences.

The discontinuation comes after a review of the medication by the European Medicines Agency which found that “the total number of deaths was higher than anticipated.”

The approval marks the only FDA-approved stand-alone therapy for the treatment of Niemann-Pick disease type C (NPC).

The study findings signal the need for improved equality in PrEP prescribing across various institutions and settings.

Thomas Chen, MD, PhD discussed his innovative approach to brain cancer treatment through NeOnc, Inc.

The decision is based on positive results from the phase 3 LAURA trial.

Artificial intelligence shows promise in improving diagnosis and treatment for patients with multiple myeloma.

Early diagnosis of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) may mitigate progression.

Automation and artificial intelligence can also aid significantly in reducing time-consuming tasks and improving efficiency for pharmacists, allowing them more time with patients.

The authors note that changes in the adolescent guidelines for meningococcal and human papillomavirus vaccines may cause inconsistencies and nonadherence.

Long-term shedding of mutated variants could pose a concern for spread among the public.

Treatment is typically tailored to the individuals, with HCT being the only curative treatment bone marrow failure, but long-term outcomes are generally poorer due to toxicities.

Although Madabhushi said there are emerging tools for clinical decision support, he said there is a greater need for tools further downstream in the post-diagnosis stages.

However, early diagnosis still presents challenges and limits treatment options.

Additional education can address ambivalence for patients and providers, which can start at the pharmacist level, as they are essential sources of information for patients.

About 72% of the observed pregnancies after allogeneic hematopoietic cell transplantation occurred spontaneously, whereas remaining pregnancies were a result of assisted reproductive activities.

Although psychotherapy is the cornerstone, nutritional education and pharmacotherapies can also help patients recover

Influenza, COVID-19, and RSV vaccines are a critical part of MTM services

As the end of the DSCSA stabilization period approaches, Josh Bolin from the NABP provides an overview of what to expect.

Researchers found that PF4/Cxcl4, a key driver of fibrosis, was up regulated on all proteomes.

Investigators reported that more than half of individuals had great knowledge about protecting themselves from COVID-19.

Compared with chemotherapy, datopotamab deruxtecan (Dato-DXd) did not achieve a statistically significant overall survival (OS) in patients with inoperable or metastatic HR+/HER2-low or negative breast cancer.

The FDA assigned a Prescription Drug User Fee Act action date of May 22, 2025.